Pacific Radiance Statistics

Total Valuation

SGX:RXS has a market cap or net worth of SGD 57.92 million. The enterprise value is 42.48 million.

Market Cap	57.92M
Enterprise Value	42.48M

Important Dates

The last earnings date was Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	May 6, 2025

Share Statistics

SGX:RXS has 1.45 billion shares outstanding. The number of shares has increased by 188.03% in one year.

Current Share Class	1.45B
Shares Outstanding	1.45B
Shares Change (YoY)	+188.03%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	73.39%
Owned by Institutions (%)	1.71%
Float	378.04M

Valuation Ratios

The trailing PE ratio is 1.63 and the forward PE ratio is 1.07.

PE Ratio	1.63
Forward PE	1.07
PS Ratio	0.97
PB Ratio	0.53
P/TBV Ratio	0.53
P/FCF Ratio	n/a
P/OCF Ratio	2.73
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.47, with an EV/FCF ratio of -7.53.

EV / Earnings	1.20
EV / Sales	0.71
EV / EBITDA	3.47
EV / EBIT	7.29
EV / FCF	-7.53

Financial Position

The company has a current ratio of 1.79, with a Debt / Equity ratio of 0.09.

Current Ratio	1.79
Quick Ratio	1.76
Debt / Equity	0.09
Debt / EBITDA	0.90
Debt / FCF	-1.70
Interest Coverage	7.42

Financial Efficiency

Return on equity (ROE) is 44.01% and return on invested capital (ROIC) is 2.34%.

Return on Equity (ROE)	44.01%
Return on Assets (ROA)	1.71%
Return on Invested Capital (ROIC)	2.34%
Return on Capital Employed (ROCE)	3.42%
Revenue Per Employee	351,961
Profits Per Employee	207,546
Employee Count	170
Asset Turnover	0.39
Inventory Turnover	177.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.56% in the last 52 weeks. The beta is 0.23, so SGX:RXS's price volatility has been lower than the market average.

Beta (5Y)	0.23
52-Week Price Change	+2.56%
50-Day Moving Average	0.04
200-Day Moving Average	0.04
Relative Strength Index (RSI)	47.40
Average Volume (20 Days)	373,825

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SGX:RXS had revenue of SGD 59.83 million and earned 35.28 million in profits. Earnings per share was 0.02.

Revenue	59.83M
Gross Profit	19.53M
Operating Income	4.18M
Pretax Income	32.98M
Net Income	35.28M
EBITDA	9.93M
EBIT	4.18M
Earnings Per Share (EPS)	0.02

Full Income Statement

Balance Sheet

The company has 24.79 million in cash and 9.57 million in debt, giving a net cash position of 15.22 million or 0.01 per share.

Cash & Cash Equivalents	24.79M
Total Debt	9.57M
Net Cash	15.22M
Net Cash Per Share	0.01
Equity (Book Value)	108.91M
Book Value Per Share	0.08
Working Capital	28.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 21.23 million and capital expenditures -26.87 million, giving a free cash flow of -5.64 million.

Operating Cash Flow	21.23M
Capital Expenditures	-26.87M
Free Cash Flow	-5.64M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 32.64%, with operating and profit margins of 6.99% and 58.97%.

Gross Margin	32.64%
Operating Margin	6.99%
Pretax Margin	55.11%
Profit Margin	58.97%
EBITDA Margin	16.59%
EBIT Margin	6.99%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.00, which amounts to a dividend yield of 1.25%.

Dividend Per Share	0.00
Dividend Yield	1.25%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-188.03%
Shareholder Yield	-186.78%
Earnings Yield	60.92%
FCF Yield	-9.73%

Dividend Details

Stock Splits

The last stock split was on September 12, 2022. It was a reverse split with a ratio of 0.1.

Last Split Date	Sep 12, 2022
Split Type	Reverse
Split Ratio	0.1

Scores

SGX:RXS has an Altman Z-Score of -0.08. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.08
Piotroski F-Score	n/a